GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $15,000 | 0.0% | 355 | +0.3% | 0.00% | +50.0% |
Q1 2022 | $15,000 | -6.2% | 354 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $16,000 | +23.1% | 354 | +0.3% | 0.00% | 0.0% |
Q3 2021 | $13,000 | -7.1% | 353 | +0.3% | 0.00% | 0.0% |
Q2 2021 | $14,000 | +7.7% | 352 | +0.3% | 0.00% | -33.3% |
Q1 2021 | $13,000 | 0.0% | 351 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $13,000 | 0.0% | 351 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $13,000 | -7.1% | 350 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $14,000 | +27.3% | 350 | +16.7% | 0.00% | 0.0% |
Q1 2020 | $11,000 | -21.4% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $14,000 | +7.7% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $13,000 | +8.3% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $12,000 | -7.7% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $13,000 | +18.2% | 300 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $11,000 | -8.3% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $12,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $12,000 | 0.0% | 300 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $12,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |